Therapeutic Treatment of Obesity, metabolic syndrome, Type 2 diabetes or prediabetes

摘要

The present Invention is directed to a method for treating a patient suffering from metabolic syndrome, Type 2 diabetes, obesity or diabetes.A method comprising the step of increasing the ratio of dopaminergic neuronal activity in noradrenergic neuronal activity in the central nervous system and, particularly,The hypothalamus of the central nervous system of the patient. (drawing, Figure 1). 1.A method for treating a patient suffering from a Metabolic disorder.A method comprising the step of administering to a patient in need of such treatment a therapeutically effective amount of a Therapeutic Product Boosting Activity Relationship of NEURForm of the dopamine / norepinefina. 2.A method for treating a patient suffering from a Metabolic disorder.A method comprising the step of administering to a patient in need of such treatment a Therapeutic Product Boosting the relationship of neuronal activity of the dopamine / noradrenaline.Increasing the ratio of dopaminergic neuronal activity in noradrenergic neuronal activity in the central nervous system, or in the hypothalamus of the central nervous system of the patient.3.A method for treating a patient suffering from untrastorno Metabolic method comprising the step of administering to a patient suffering from metabolic syndrome, Type 2 diabetes, obesity,Or prediabetes, a Pharmaceutical composition containing at least one (1) compound that stimulates an increase in level of Central dopaminergic neuronal activity in the subject,And (2) at least one compound that stimulates a decrease in the level of Central noradrenergic neuronal activity in the subject.